[{"id":12325,"run_id":438,"as_of":"2026-09-11","ticker":"RLMD","company":"Relmada Therapeutics, Inc.","source":"weekly","conviction":55.2,"technical":50.1,"stage":"No Long Regime","gated":true,"n_gates":3,"gates":["Price below the 200DMA — no long regime.","50DMA is not rising.","Price $4.52 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":4.52,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":6.8,"Volatility behaviour":13.0,"Cross-asset confirmation":7.3,"Sponsorship / positioning":13.0,"Catalyst alignment (insider)":15.1},"total_cfo_value":843990.0,"total_other_value":828000.0,"n_cfo_buys":1.0,"n_other_buys":1.0,"has_cfo_buy":true,"roles_buying":"1 CFO, 1 CEO","npr":1.0,"cluster_insiders":2.0,"days_since_buy":2.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-11T21:13:17.292546+00:00"},{"id":12926,"run_id":440,"as_of":"2026-09-14","ticker":"RLMD","company":"Relmada Therapeutics, Inc.","source":"weekly","conviction":56.3,"technical":51.5,"stage":"No Long Regime","gated":true,"n_gates":3,"gates":["Price below the 200DMA — no long regime.","50DMA is not rising.","Price $4.44 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":4.44,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":7.1,"Volatility behaviour":13.0,"Cross-asset confirmation":8.1,"Sponsorship / positioning":13.0,"Catalyst alignment (insider)":15.1},"total_cfo_value":843990.0,"total_other_value":828000.0,"n_cfo_buys":1.0,"n_other_buys":1.0,"has_cfo_buy":true,"roles_buying":"1 CFO, 1 CEO","npr":1.0,"cluster_insiders":2.0,"days_since_buy":5.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-14T21:02:09.279670+00:00"},{"id":13518,"run_id":442,"as_of":"2026-09-15","ticker":"RLMD","company":"Relmada Therapeutics, Inc.","source":"weekly","conviction":57.1,"technical":52.5,"stage":"No Long Regime","gated":true,"n_gates":3,"gates":["Price below the 200DMA — no long regime.","50DMA is not rising.","Price $4.44 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":4.44,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":7.5,"Volatility behaviour":13.0,"Cross-asset confirmation":8.5,"Sponsorship / positioning":13.0,"Catalyst alignment (insider)":15.1},"total_cfo_value":843990.0,"total_other_value":828000.0,"n_cfo_buys":1.0,"n_other_buys":1.0,"has_cfo_buy":true,"roles_buying":"1 CFO, 1 CEO","npr":1.0,"cluster_insiders":2.0,"days_since_buy":6.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-15T21:04:48.311557+00:00"},{"id":14117,"run_id":444,"as_of":"2026-09-16","ticker":"RLMD","company":"Relmada Therapeutics, Inc.","source":"weekly","conviction":58.5,"technical":54.2,"stage":"No Long Regime","gated":true,"n_gates":3,"gates":["Price below the 200DMA — no long regime.","50DMA is not rising.","Price $4.22 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":4.22,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":8.0,"Volatility behaviour":13.0,"Cross-asset confirmation":9.4,"Sponsorship / positioning":13.0,"Catalyst alignment (insider)":15.1},"total_cfo_value":843990.0,"total_other_value":828000.0,"n_cfo_buys":1.0,"n_other_buys":1.0,"has_cfo_buy":true,"roles_buying":"1 CFO, 1 CEO","npr":1.0,"cluster_insiders":2.0,"days_since_buy":7.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-16T21:30:15.198638+00:00"},{"id":14711,"run_id":451,"as_of":"2026-09-17","ticker":"RLMD","company":"Relmada Therapeutics, Inc.","source":"weekly","conviction":58.3,"technical":54.0,"stage":"No Long Regime","gated":true,"n_gates":3,"gates":["Price below the 200DMA — no long regime.","50DMA is not rising.","Price $4.20 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":4.2,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":8.0,"Volatility behaviour":13.0,"Cross-asset confirmation":9.2,"Sponsorship / positioning":13.0,"Catalyst alignment (insider)":15.1},"total_cfo_value":843990.0,"total_other_value":828000.0,"n_cfo_buys":1.0,"n_other_buys":1.0,"has_cfo_buy":true,"roles_buying":"1 CFO, 1 CEO","npr":1.0,"cluster_insiders":2.0,"days_since_buy":8.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-17T21:06:22.295534+00:00"},{"id":15317,"run_id":455,"as_of":"2026-10-14","ticker":"RLMD","company":"Relmada Therapeutics, Inc.","source":"weekly","conviction":39.5,"technical":30.6,"stage":"No Long Regime","gated":true,"n_gates":3,"gates":["Price below the 200DMA — no long regime.","50DMA is not rising.","Price $3.24 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":3.24,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":8.0,"Volatility behaviour":9.5,"Cross-asset confirmation":0.0,"Sponsorship / positioning":7.0,"Catalyst alignment (insider)":15.0},"total_cfo_value":843990.0,"total_other_value":828000.0,"n_cfo_buys":1.0,"n_other_buys":1.0,"has_cfo_buy":true,"roles_buying":"1 CFO, 1 CEO","npr":1.0,"cluster_insiders":2.0,"days_since_buy":35.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-10-14T21:57:05.171892+00:00"},{"id":15400,"run_id":456,"as_of":"2026-10-15","ticker":"RLMD","company":"Relmada Therapeutics, Inc.","source":"weekly","conviction":48.1,"technical":41.4,"stage":"No Long Regime","gated":true,"n_gates":4,"gates":["Price below the 200DMA — no long regime.","200DMA is not rising — regime not clear.","50DMA is not rising.","Price $3.20 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":3.2,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":2.6,"Volatility behaviour":9.5,"Cross-asset confirmation":14.0,"Sponsorship / positioning":7.0,"Catalyst alignment (insider)":15.0},"total_cfo_value":843990.0,"total_other_value":828000.0,"n_cfo_buys":1.0,"n_other_buys":1.0,"has_cfo_buy":true,"roles_buying":"1 CFO, 1 CEO","npr":1.0,"cluster_insiders":2.0,"days_since_buy":36.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-10-15T21:13:44.615367+00:00"},{"id":15993,"run_id":458,"as_of":"2026-10-16","ticker":"RLMD","company":"Relmada Therapeutics, Inc.","source":"weekly","conviction":48.5,"technical":41.9,"stage":"No Long Regime","gated":true,"n_gates":4,"gates":["Price below the 200DMA — no long regime.","200DMA is not rising — regime not clear.","50DMA is not rising.","Price $3.10 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":3.1,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":3.0,"Volatility behaviour":9.5,"Cross-asset confirmation":14.0,"Sponsorship / positioning":7.0,"Catalyst alignment (insider)":15.0},"total_cfo_value":843990.0,"total_other_value":828000.0,"n_cfo_buys":1.0,"n_other_buys":1.0,"has_cfo_buy":true,"roles_buying":"1 CFO, 1 CEO","npr":1.0,"cluster_insiders":2.0,"days_since_buy":37.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-10-16T20:55:56.165619+00:00"}]